Vector Biosystems - 19104 Philadelphia, PA

Business Name: Vector Biosystems
Categorized In: Commercial Biotechnical Research
Address: 3624 Market St # 5e, Philadelphia, PA 19104
Phone Number: (610) 563-6563
Contact Person: Xiaong Shao
Website Address: vectorbiolabs.com
NAICS Code: 541711
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2004
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Oncovirx - Philadelphia, PA 19104
Diathera LLC - Philadelphia, PA 19104
Pathopartitions - Philadelphia, PA 19104
Vibe Pharmaceuticals - Philadelphia, PA 19104
Biotech Studio LLC - Philadelphia, PA 19104
Aum Lifetech Inc - Philadelphia, PA 19104
Metamorphosis LLC - Philadelphia, PA 19104
Microbiota Therapeutics - Philadelphia, PA 19104
Penzymes LLC - Philadelphia, PA 19104
Navirx LLC - Philadelphia, PA 19104
Betaplus Radiopharmaceuticals LLC - Philadelphia, PA 19104
Lignamed LLC - Philadelphia, PA 19104
Pathonomics - Philadelphia, PA 19104
Amyndas Biotherapeutics LLC - Philadelphia, PA 19104
Skelegen - Philadelphia, PA 19104
Cartcentric Diagnostics - Philadelphia, PA 19104
Liquid Biotech - Philadelphia, PA 19104
Epigen Cardio LLC - Philadelphia, PA 19104
Intervir Therapeutics - Philadelphia, PA 19104

Vector Biosystems provides professional Commercial Biotechnical Research from its single location at the coordinates 39.956264,-75.19595.

The company offers B2B variables under the SIC code 8731 and NAICS code 541711, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2004, the company can now be visited at 3624 Market St # 5e, Philadelphia, Pennsylvania 19104 or contacted through representative Xiaong Shao at (610) 563-6563.

For frequently asked questions and further inquiries about professional Commercial Biotechnical Research, get to know more about Vector Biosystems through its company website at vectorbiolabs.com. Engage with this business on its social media platforms through on Twitter and on Facebook.